Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Catalyst Biosciences, Inc.”

26 pharma patents match "Catalyst Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 26
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 26 pharmaceutical patents matching "Catalyst Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

26 results for “Catalyst Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 11491212

    Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

    Catalyst Biosciences, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  2. US 11401513

    Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Catalyst Biosciences, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  3. US 11266724

    Modified factor VII polypeptides for subcutaneous administration and on-demand treatment

    Catalyst Biosciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  4. US 11203749

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  5. US 10982203

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  6. US 10954501

    Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Catalyst Biosciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  7. US 10781435

    Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Catalyst Biosciences, Inc. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  8. US 10716770

    Nicotinic receptor non-competitive antagonists

    Catalyst Biosciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  9. US 10258582

    Nicotinic receptor non-competitive antagonists

    Catalyst Biosciences, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted
  10. US 10160961

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted
  11. US 9856467

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  12. US 9795655

    Modified MT-SP1 proteases that inhibit complement activation

    Catalyst Biosciences, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  13. US 9476037

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  14. US 9359598

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  15. US 9328339

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  16. US 9290757

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted
  17. US 9145552

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  18. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  19. US 8663633

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  20. US 8519103

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  21. US 8445245

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  22. US 8383388

    Modified coagulation factor IX polypeptides and use thereof for treatment

    Catalyst Biosciences, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  23. US 8211428

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  24. US 7939304

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted May 10, 2011 · Expires May 5, 2031

    granted